Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

4-

Heinz1, Hegetschweiler, Acklin

  • 1Universität des Saarlandes, Anorganische Chemie, Postfach 15 11 50, D-66041 Saarbrücken (Germany).

Angewandte Chemie (International Ed. in English)
|October 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Entry distribution, fission barrier, and formation mechanism of 254102No

Physical review letters·2000
Same author

The 44Ti(alpha,p) reaction and its implication on the 44Ti yield in supernovae

Physical review letters·2000
Same author

Facially coordinating cyclic triamines, part I. The coordination chemistry of cis-3,5-diaminopiperidine and substituted derivatives

Chemistry (Weinheim an der Bergstrasse, Germany)·2000
Same author

Fluctuation probes of quark deconfinement

Physical review letters·2000
Same author

The enzymes for galactolipid biosynthesis are nearly all cloned: so what next?

Trends in plant science·1999
Same author

A Shotgun Model for Gamma-Ray Bursts.

The Astrophysical journal·1999
Same journal

A Domino-Synthesized Dicoordinate Copper(I) Bis-imidazopyridine Complex Triggering Cuproptosis/Ferroptosis for Enhanced Cancer Immunotherapy.

Angewandte Chemie (International ed. in English)·2026
Same journal

Mirror-Symmetric Organic Two-Dimensional Crystals for Alternative Photon Transport Pathways.

Angewandte Chemie (International ed. in English)·2026
Same journal

Cobalt-Catalyzed Migratory E-Selective Asymmetric Aza-Nozaki-Hiyama-Kishi Coupling.

Angewandte Chemie (International ed. in English)·2026
Same journal

Facile Synthesis of α,ω-Dihydroxy Telechelic Macromonomers From Ethylene and α-Olefins for Recyclable Alternating Block Copolymers.

Angewandte Chemie (International ed. in English)·2026
Same journal

Multi-Atom Sub-Nanometer Assemblies on Interpenetrating Multi-Chambered N/C Nanospheres.

Angewandte Chemie (International ed. in English)·2026
Same journal

A Synergistic C<sub>2+</sub> Alcohols/Olefins-Intermediated Pathway Boosts CO<sub>2</sub> Hydrogenation to Aromatics.

Angewandte Chemie (International ed. in English)·2026
See all related articles

A novel ligand, H(3)L, forms a highly stable complex with iron(III), showing low affinity for other metals. This selectivity suggests potential medical uses, particularly for treating iron overload conditions.

Area of Science:

  • Inorganic Chemistry
  • Medicinal Chemistry
  • Biometallochemistry

Background:

  • Iron overload disorders require effective chelation therapy.
  • Development of selective metal-binding ligands is crucial for therapeutic applications.

Purpose of the Study:

  • To synthesize and characterize a novel ligand, H(3)L.
  • To investigate the complexation behavior of H(3)L with Fe(III) and other biologically relevant metal ions.
  • To evaluate the potential of H(3)L for medical applications, specifically in iron overload treatment.

Main Methods:

  • Synthesis of the ligand H(3)L.
  • Spectroscopic and crystallographic analysis of the Fe(III) complex.
  • Metal-binding affinity studies using various biometals.

Related Experiment Videos

Main Results:

  • Formation of an exceptionally stable 1:2 complex, [FeL(2)](3-), with Fe(III).
  • The ligand H(3)L exhibits significantly lower affinity for other tested biometals.
  • High selectivity and stability of the iron complex were confirmed.

Conclusions:

  • The ligand H(3)L demonstrates remarkable selectivity for Fe(III) over other biometals.
  • The stable [FeL(2)](3-) complex holds significant promise for developing new therapeutic agents.
  • H(3)L is a strong candidate for treating iron overload diseases.